Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I trial to evaluate the safety and immunogenicity of rMVA-HIV(rMVA-HIV env/gag+rMVA-HIV tat/rev/nef-RT) and rFPV-HIV (rFPV-HIV env/gag+rFPV-HIV tat/rev/nef-RT) vaccines, alone or in combiniation in healthy, vaccinia-naive HIV-1 negative participants
Description
HVTN 055 is a Phase I clinical trial to evaluate the safety and immunogenicity of rMVA-HIV and rFPV-HIV.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.